The Breast · 2015 · 27 citations · 26 references
MedicineOncologyRadiologyBreast OncologyChemotherapyOncologic ImagingBreast ImagingNeoadjuvant ChemotherapyNeoadjuvant TherapyTherapy Response AssessmentTumor CharacterizationTumor ImagingBreast Cancer ChemotherapyBreast Cancer PrognosisBreast Cancer Response AssessmentBreast Imaging FindingsChemotherapy Response AssessmentImaging Response CriteriaTherapy Response EvaluationTumor Response Evaluation
The purpose of this study was to evaluate whether the baseline breast MRI findings would be useful for the prediction for pathological complete response (pCR) by breast cancer patients to neoadjuvant chemotherapy. Primary breast cancer patients (stage II-III) preoperatively treated with sequential paclitaxel (12 cycles) and fluorouracil, epirubicin, and cyclophosphamide (4 cycles), followed by surgery were retrospectively enrolled, and 229 patients were eligible. Before chemotherapy, breast MRI studies were performed. Breast tumors were dichotomized into round + oval and irregular types based on MRI morphology. The round + oval tumors showed a significantly higher pCR rate than the irregular tumors (42.0% vs 17.3%; P < 0.001). In addition, PAM50 analysis revealed that basal and HER2-enriched tumors were significantly more prevalent among round + oval than irregular type tumors (P = 0.015). Baseline MRI morphology appears to be a significant predictor for pCR. The higher rate of the basal and HER2-enriched tumors among the round + oval tumors may explain their better chemo-sensitivity.
26
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker, Michael E. Mullins, Maggie C.U. Cheang et al. · Journal of Clinical Oncology · 2009 · 4.9K citations · Full text
Medicine, Bioinformatics, Oncology +16
Bernard Fisher, A Brown, E.P. Mamounas et al. · Journal of Clinical Oncology · 1997 · 1.8K citations
Harry D. Bear, Stewart Anderson, Ann Brown et al. · Journal of Clinical Oncology · 2003 · 1.1K citations
Manfred Kaufmann, Gabriel N. Hortobágyi, Aron Goldhirsch et al. · Journal of Clinical Oncology · 2006 · 721 citations · Full text